AR036036A1 - Compuesto heterociclico, composicion farmaceutica que lo contiene y su uso para la preparacion de la misma - Google Patents
Compuesto heterociclico, composicion farmaceutica que lo contiene y su uso para la preparacion de la mismaInfo
- Publication number
- AR036036A1 AR036036A1 ARP020102002A ARP020102002A AR036036A1 AR 036036 A1 AR036036 A1 AR 036036A1 AR P020102002 A ARP020102002 A AR P020102002A AR P020102002 A ARP020102002 A AR P020102002A AR 036036 A1 AR036036 A1 AR 036036A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- agent
- hydrogen atom
- aryl
- atom
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Child & Adolescent Psychology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Un compuesto heterocíclico que tiene la fórmula (1) donde R1 es un átomo de hidrógeno o alquilo C1-6; R2 es un átomo de hidrógeno, -CO-R3, donde R3 es alquilo C2-6 opcionalmente sustituido por halógeno, -CO-C(R4)=C(R4)-R5, donde R4 es opcionalmente el mismo que el otro R4 y es un átomo de hidrógeno o alquilo C1-4 y R5 es alquilo C1-8, alquenilo C2-8, arilo o un heterociclo aromático, -CO-C:::C-R6, donde R6 es alquilo C1-8, fórmula (2) donde m es un número entero de 2 a 7, arilo, arilalquilo C1-3 opcionalmente sustituido, alquilo C1-6 opcionalmente sustituido por halógeno, alquenilo C2-6, cicloalquilo C3-8 o cicloalquil C3-8-alquilo C1-3; Y es fórmula (3) donde R7 es un átomo de hidrógeno o alquilo C1-4; R8 es alquilo C5-8, cicloalquilo C4-8, alquiltio C1-4-alquilo C1-6, R10-C(R9)=C(R9)-, donde R9 es opcionalmente el mismo que el otro R9 y es un átomo de hidrógeno o alquilo C1-4 y R10 es alquilo C1-6 opcionalmente sustituido por halógeno, alquenilo C2-8, arilo, un heterociclo aromático, cicloalquilo C3-8, cicloalquil C3-8-alquilo C1-3, alcoxi C1-4-alquilo C1-6, alquiltio C1-4-alquilo C1-6 o alquilo C1-6 sustituido por (R9)2N-, donde R9 es opcionalmente el mismo que el otro R9 y es un átomo de hidrógeno o alquilo C1-4, R12-CO-N(R11)-, donde R11 es un átomo de hidrógeno o alquilo C1-4 y R12 es alquilo C1-6 o arilo, R13-Z-, donde R13 es alquilo C1-8 o arilo y Z es un átomo de oxígeno o un átomo de azufre; o fórmula (4) donde k es un número entero de 2 a 7 y X es un átomo de oxígeno o un átomo de azufre, o R15-C(R14)=N-O-, donde R14 es un átomo de hidrógeno o alquilo C1-4 y R15 es arilo o un heterociclo aromático; Y-(CH2)n-O- está enlazado a la posición 6 o 7 de un esqueleto de tetrahidroisoquinolina; y n es un número entero de 1 a 4, o una sal farmacéuticamente aceptable del mismo. Composición farmacéutica que lo comprende y su uso para prepararla, siendo útil como agente hipoglucémico, un agente hipolipidémico, un mejorador de la resistencia a la insulina, un agente terapéutico de la diabetes, un agente terapéutico de complicaciones diabéticas, un mejorador de la tolerancia a la glucosa, un agente antiarterioesclerosis, un agente antiobesidad, un agente antiinflamatorio, un agente para la profilaxis o tratamiento de enfermedades mediadas por PPAR o un agente para la profilaxis o el tratamiento del síndrome X.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001161489 | 2001-05-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR036036A1 true AR036036A1 (es) | 2004-08-04 |
Family
ID=19004756
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP020102002A AR036036A1 (es) | 2001-05-29 | 2002-05-29 | Compuesto heterociclico, composicion farmaceutica que lo contiene y su uso para la preparacion de la misma |
Country Status (23)
Country | Link |
---|---|
US (1) | US7557123B2 (es) |
EP (1) | EP1403253A4 (es) |
JP (1) | JP4279136B2 (es) |
KR (2) | KR20040030647A (es) |
CN (1) | CN1242994C (es) |
AR (1) | AR036036A1 (es) |
AU (1) | AU2002308889B2 (es) |
BR (1) | BR0209711A (es) |
CA (1) | CA2448634A1 (es) |
CO (1) | CO5540342A2 (es) |
CZ (1) | CZ20033450A3 (es) |
HK (1) | HK1069385A1 (es) |
HU (1) | HUP0401862A3 (es) |
IL (1) | IL159085A0 (es) |
MX (1) | MXPA03010811A (es) |
NO (1) | NO326688B1 (es) |
NZ (1) | NZ530358A (es) |
PL (1) | PL367639A1 (es) |
RU (1) | RU2299197C2 (es) |
TW (1) | TWI297008B (es) |
WO (1) | WO2002096880A1 (es) |
YU (1) | YU94003A (es) |
ZA (1) | ZA200309757B (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4279137B2 (ja) | 2001-05-29 | 2009-06-17 | 京都薬品工業株式会社 | 新規複素環誘導体およびその医薬用途 |
US7816385B2 (en) * | 2002-12-20 | 2010-10-19 | High Point Pharmaceuticals, Llc | Dimeric dicarboxylic acid derivatives, their preparation and use |
JPWO2004106542A1 (ja) * | 2003-05-29 | 2006-07-20 | 三共株式会社 | インスリン抵抗性改善剤及びそのスクリーニング方法 |
TWI359810B (en) * | 2004-11-04 | 2012-03-11 | Mitsubishi Tanabe Pharma Corp | Carboxylic acid derivative containing thiazole rin |
US7790745B2 (en) | 2005-10-21 | 2010-09-07 | Bristol-Myers Squibb Company | Tetrahydroisoquinoline LXR Modulators |
WO2007058504A1 (en) * | 2005-11-21 | 2007-05-24 | Lg Life Sciences, Ltd. | Novel compounds as agonist for ppar gamma and ppar alpha, method for preparation of the same, and pharmaceutical composition containing the same |
WO2012033195A1 (ja) * | 2010-09-10 | 2012-03-15 | 京都薬品工業株式会社 | 複素環化合物 |
CN102807526B (zh) * | 2011-06-21 | 2015-12-02 | 寿光富康制药有限公司 | 组蛋白去乙酰化酶抑制剂ZYJ-D08a及其差向异构体的制备方法与应用 |
WO2020013116A1 (ja) * | 2018-07-10 | 2020-01-16 | 京都薬品工業株式会社 | Ptp-1b阻害剤およびその用途 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6051189A (ja) * | 1983-08-30 | 1985-03-22 | Sankyo Co Ltd | チアゾリジン誘導体およびその製造法 |
AR240698A1 (es) * | 1985-01-19 | 1990-09-28 | Takeda Chemical Industries Ltd | Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales |
EP0842925A1 (en) * | 1987-09-04 | 1998-05-20 | Beecham Group Plc | Substituted thiazolidinedione derivatives |
US5246943A (en) | 1992-05-19 | 1993-09-21 | Warner-Lambert Company | Substituted 1,2,3,4-tetahydroisoquinolines with angiotensin II receptor antagonist properties |
GB9604242D0 (en) | 1996-02-28 | 1996-05-01 | Glaxo Wellcome Inc | Chemical compounds |
ATE277907T1 (de) * | 1996-07-01 | 2004-10-15 | Lilly Co Eli | Blutzuckersenkende und lipidsenkende verbindungen |
AU3719997A (en) | 1996-07-01 | 1998-01-21 | Eli Lilly And Company | Hypoglycemic and hypolipidemic compounds |
GB9817118D0 (en) | 1998-08-07 | 1998-10-07 | Glaxo Group Ltd | Pharmaceutical compounds |
MXPA02005528A (es) * | 1999-12-03 | 2002-09-02 | Kyoto Pharma Ind | Compuestos heterociclicos sus sales y uso medicinal. |
US20020037897A1 (en) * | 2000-08-07 | 2002-03-28 | 3-Dimensional Pharmaceuticals, Inc. | Tetrahydroisoquinoline-3-carboxylic acid alkoxyguanidines as integrin antagonists |
JP4279137B2 (ja) * | 2001-05-29 | 2009-06-17 | 京都薬品工業株式会社 | 新規複素環誘導体およびその医薬用途 |
-
2002
- 2002-05-27 CN CNB028109643A patent/CN1242994C/zh not_active Expired - Fee Related
- 2002-05-27 HU HU0401862A patent/HUP0401862A3/hu unknown
- 2002-05-27 ZA ZA200309757A patent/ZA200309757B/en unknown
- 2002-05-27 YU YU94003A patent/YU94003A/sh unknown
- 2002-05-27 US US10/478,862 patent/US7557123B2/en not_active Expired - Fee Related
- 2002-05-27 RU RU2003137574/04A patent/RU2299197C2/ru not_active IP Right Cessation
- 2002-05-27 BR BR0209711-7A patent/BR0209711A/pt not_active IP Right Cessation
- 2002-05-27 WO PCT/JP2002/005097 patent/WO2002096880A1/ja active Application Filing
- 2002-05-27 KR KR10-2003-7015611A patent/KR20040030647A/ko not_active IP Right Cessation
- 2002-05-27 CA CA002448634A patent/CA2448634A1/en not_active Abandoned
- 2002-05-27 CZ CZ20033450A patent/CZ20033450A3/cs unknown
- 2002-05-27 AU AU2002308889A patent/AU2002308889B2/en not_active Ceased
- 2002-05-27 PL PL02367639A patent/PL367639A1/xx unknown
- 2002-05-27 KR KR1020087023698A patent/KR100898358B1/ko not_active IP Right Cessation
- 2002-05-27 EP EP02774070A patent/EP1403253A4/en not_active Withdrawn
- 2002-05-27 MX MXPA03010811A patent/MXPA03010811A/es active IP Right Grant
- 2002-05-27 NZ NZ530358A patent/NZ530358A/en unknown
- 2002-05-27 IL IL15908502A patent/IL159085A0/xx unknown
- 2002-05-27 JP JP2003500060A patent/JP4279136B2/ja not_active Expired - Fee Related
- 2002-05-28 TW TW091111315A patent/TWI297008B/zh active
- 2002-05-29 AR ARP020102002A patent/AR036036A1/es unknown
-
2003
- 2003-11-28 NO NO20035331A patent/NO326688B1/no not_active IP Right Cessation
- 2003-12-29 CO CO03112806A patent/CO5540342A2/es not_active Application Discontinuation
-
2005
- 2005-03-02 HK HK05101815A patent/HK1069385A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NO20035331D0 (no) | 2003-11-28 |
CN1242994C (zh) | 2006-02-22 |
KR20080093076A (ko) | 2008-10-17 |
MXPA03010811A (es) | 2004-02-27 |
IL159085A0 (en) | 2004-05-12 |
HUP0401862A2 (hu) | 2004-12-28 |
CO5540342A2 (es) | 2005-07-29 |
EP1403253A1 (en) | 2004-03-31 |
CZ20033450A3 (cs) | 2004-05-12 |
BR0209711A (pt) | 2004-11-03 |
JP4279136B2 (ja) | 2009-06-17 |
KR100898358B1 (ko) | 2009-05-20 |
JPWO2002096880A1 (ja) | 2004-09-09 |
PL367639A1 (en) | 2005-03-07 |
CA2448634A1 (en) | 2002-12-05 |
AU2002308889B2 (en) | 2007-09-06 |
TWI297008B (en) | 2008-05-21 |
US20040220215A1 (en) | 2004-11-04 |
ZA200309757B (en) | 2004-12-22 |
EP1403253A4 (en) | 2005-03-30 |
CN1527819A (zh) | 2004-09-08 |
WO2002096880A1 (fr) | 2002-12-05 |
NO326688B1 (no) | 2009-01-26 |
HUP0401862A3 (en) | 2009-03-30 |
RU2299197C2 (ru) | 2007-05-20 |
NZ530358A (en) | 2005-04-29 |
US7557123B2 (en) | 2009-07-07 |
RU2003137574A (ru) | 2005-05-20 |
YU94003A (sh) | 2006-08-17 |
HK1069385A1 (en) | 2005-05-20 |
KR20040030647A (ko) | 2004-04-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60218048D1 (de) | Thiophenverbindungen als arzneimittel | |
BRPI0513752A (pt) | derivado de ciclohexano, pró-droga do mesmo e sal do mesmo e agente terapêutico contendo o mesmo para diabetes | |
BR0211665A (pt) | Composto, composição farmacêutica, método para a redução de glicose, método para a prevenção ou para tratamento de doenças, medicamento para a redução de glicose, medicamento para a prevenção ou para o tratamento de doenças, uso do composto, da composição farmacêutica e do medicamento e processo para a preparação do composto | |
NZ508066A (en) | Oxyiminoalkanoic acid derivatives with hypoglycemic and hypolipidemic activity | |
PT1045830E (pt) | Derivados alfa-aminoamidas uteis como agentes analgesicos | |
MXPA05008600A (es) | Compuestos para el tratamiento de desordenes metabolicos. | |
AR036036A1 (es) | Compuesto heterociclico, composicion farmaceutica que lo contiene y su uso para la preparacion de la misma | |
NO20054791D0 (no) | Forbindelser for behandling av stoffskiftesykdommer | |
NO20050569L (no) | Fremgangsmate for behandling av alvorlig hjertesvikt og medikament for dette | |
AR036037A1 (es) | Compuesto heterociclico, composicion farmaceutica que lo comprende y su uso para la preparacion de esta ultima | |
ATE526018T1 (de) | Verbindungen zur behandlung von stoffwechselstörungen | |
RU2008101661A (ru) | Замещенное циклическое соединение, способ его получения и его лекарственное применение | |
ATE420853T1 (de) | 5-amidino-2-hydroxybenzolsulfonamidderivate, pharmazeutischen zusammensetzungen, die diese verbindungen enthalten, und zwischenprodukte zu deren herstellung | |
KR900701716A (ko) | 치환된 β-디 케톤류 | |
AR044869A1 (es) | Compuesto de dicetopiperazina, composicion farmaceutica que lo comprende, su uso para fabricar un medicamento y procedimiento para su preparacion | |
ES2059348T3 (es) | Composicion farmaceutica para el tratamiento de cataratas. | |
SE0101978D0 (sv) | New compounds | |
DK1179342T3 (da) | Medicinske sammensætninger til öjeblikkelig frigivelse ved oral anvendelse | |
DE60013560D1 (de) | Malto-oligosaccharid-derivate und ihre anwendungen | |
KR940002268A (ko) | 21-클로로-프레그난 유도체 | |
MXPA98001514A (es) | Opiatos hiperalgesico activos perifericamente |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |